neural crest. By manipulating the levels of Pax3 and Zic1 in isolated animal explants, we can generate a fairly pure population of neural crest progenitors independently of the induction of other neural plate border cell types. Taking advantage of this explant-system we conducted a microarray screen in Xenopus to isolate genes synergistically activated by Pax3 and Zic1. The characterization of these targets is expected to expand our understanding of the gene regulatory network underlying neural crest formation. We identified over 100 genes that were upregulated two folds or more, among which are a number of well-studied neural crest specifiers, including Foxd3, Twist, Snail2, Sox8, Sox9 and Inca, which fully validates our approach. The rest of the genes are either novel or had no known function in neural crest formation. They represent potential regulators of gene transcription, signal transduction and cell signaling, as well as genes with yet uncharacterized function. The egg-laying organ of C. elegans, the vulva, is an excellent model to study cell-cell communication during development. The interplay between conserved signalling pathways such as DELTA/NOTCH and EGFR/RAS/MAPK is crucial to establish the proper cell fate pattern during vulval development. The detailed knowledge of the components constituting these signalling pathways permits us to create computational models of vulval fate specification (Fisher et al., 2007, the PANACEA project) . By comparing the predictions made by computational modelling with the actual alterations in the vulval cell fate patterns observed in different mutants, we can identify gaps in our understanding and make novel predictions. One insight gained by computational modelling suggests that a global timing mechanism must exist in order to synchronise the differentiation status of the vulval precursor cells (VPCs) within certain limits. We thus investigated the influence of the VPC cell cycle on vulval cell fate specification. We discovered that the degradation of the NOTCH receptor (LIN-12) is tightly linked to cell cycle progression. When the VPCs are arrested in the G1 or S phase using tissue-specific expression of the CDK inhibitor CKI-1 or by hydroxyurea treatment, the NOTCH reporter fails to be degraded in cells of the 1°lineage and instead accumulated in the nucleus and cytoplasm. Moreover, a downstream target of LIN-12 NOTCH, which is normally not expressed in the 1°lineage, continues to be expressed in the arrested VPCs. We will present the results of a mutant analysis of different cell cycle components used to identify the link between cell cycle progression and NOTCH degradation. Inductive signals from adjacent tissues mediate initial pattern formation within the somite. Here we focused on how the Hh and BMP pathways interact during sclerotome specification. We confirmed the absence of somitic Pax1 and Pax9 expression in embryos mutant for the BMP antagonists Noggin and Gremlin1, consistent with the loss of sclerotome. Furthermore, Noggin mutants also lacking one allele of Gremlin1 exhibited a dramatic reduction in axial skeleton relative to embryos mutant for Noggin alone. In contrast, expression of Pax3, Myf5 and Lbx1 indicated dermomyotome induction persists in double mutants. Conditional Bmpr1a mutation or BMP type-1 receptor (BMPR1) inhibition did not alter sclerotome marker expression, suggesting that BMP antagonists lack an instructive function in sclerotome specification. We found that BMPR1 inhibition restored sclerotome induction in Noggin:Gremlin1 double mutants, demonstrating that elevated BMP blocks sclerotome formation. However, this treatment did not rescue Pax1 expression in Smoothened mutants, suggesting that inhibition of BMP-signaling is not sufficient to induce sclerotome in the absence of Hh-signaling. Furthermore, Smoothened activation did not rescue Pax1 expression in Noggin:Gremlin1 double mutants, demonstrating aberrant Hhsignal transduction. We conclude that Noggin and Gremlin1 cooperate to maintain a BMP signaling free zone that is a critical prerequisite for Hh-mediated sclerotome specification. We are currently using the chick system examine how BMP may alter the conformation of Gli transcription factors and have initiated tissue engineering studies to develop in vitro models to dissect the mechanism by which BMP affects the outcome of Hh signaling. During embryonic development, epicardial cells undergo epithelial-to-mesenchymal transition to form epicardium-derived cells (EPDCs), which invade the myocardium and differentiate into fibroblasts, smooth muscle, and endothelial cells. Immunofluorescence studies demonstrate that the transcription factors (TF) Pod1, WT1, Tbx18, and NFATc1 are expressed in overlapping and distinct EPDC subpopulations in chicken and mouse hearts. Multiple inductive factors including retinoic acid (RA), Wnt, BMP, and FGF influence EPDC development. The upstream regulation of TF expression in EPDCs was examined in isolated chick embryonic day 7 (E7) EPDCs. Expression of Pod1 and WT1, but not Tbx18 or NFATc1, is upregulated with all-trans-RA treatment, as determined by quantitative RT-PCR. BMP2, Wnt3a, or FGF2 treatment does not significantly affect TF gene expression levels in isolated EPDCs. Similar induction of Pod1 and WT1 expression in EPDCs occurs with RA treatment of intact CE7 hearts. In addition, RA treatment inhibits smooth muscle differentiation as indicated by SM22α expression, while treatment with the RALDH2 inhibitor DEAB increases SM22α in CE7 hearts in vitro. Current experiments are investigating if Pod1 is a direct downstream target of RA receptors and if Pod1 is required to inhibit EPDC differentiation into smooth muscle in vivo in mice. These data support our hypothesis that RA promotes Pod1 and WT1 expression while inhibiting smooth muscle differentiation in EPDCs. 
